# Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)

> **NCT01029925** · PHASE2 · TERMINATED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 7 (actual)

## Conditions studied

- Metastatic Breast Cancer
- Lung Cancer

## Interventions

- **DRUG:** Dichloroacetate (DCA)

## Key facts

- **NCT ID:** NCT01029925
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2011-08
- **Final completion:** 2011-11
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** DSMB determined, due to higher than expected risk/safety concerns, study should be closed.
- **Last updated:** 2016-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01029925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01029925, "Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01029925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*